How is AI revolutionizing oncology data? Find out in this special 'New Frontiers' episode (aired on Bloomberg) that explores the evolution of AI-powered oncology Data Intelligence with LARVOL. ? #LARVOL #BloombergTV #NewFrontiers #Tech #Healthcare #Oncology #CancerResearch #Cancer #CancerData #OncologyData | Bruno Larvol
LARVOL
IT 服务与咨询
San Francisco，California 13,006 位关注者
Empowering pharma, biotech, and life sciences with customized SaaS and expert intelligence since 2004.
关于我们
Customized intelligence reports and SaaS solutions - We provide healthcare and life sciences experts accurate, rapid, expertly-curated information to enable strategic decision-making. Our products include KOL monitoring, real-time high-impact news, intuitive cancer biomarker database and comprehensive conference planners. To keep you at the forefront of clinical and industry developments, LARVOL curates pharmaceutical and biotech competitive intelligence using a proven combination of broad therapeutic-area expertise and technological innovation. Our team of MDs and PhDs collates data from over 25,000 sources and distills the most relevant findings into concise reports that provide real-time insights and time-saving analysis. Our global team is comprised of professionals with expertise in all major therapeutic areas, with a special focus on oncology, inflammation, cardiovascular, and CNS. We are a valued partner to numerous Fortune 500 companies as well as small and mid-size pharma and biotech enterprises.
- 网站
-
https://www.larvol.com
LARVOL的外部链接
- 所属行业
- IT 服务与咨询
- 规模
- 51-200 人
- 总部
- San Francisco，California
- 类型
- 私人持股
- 创立
- 2004
- 领域
- Financial analyst monitoring、Scientific Conferences、life sciences、medical conferences和healthcare
产品
![点击此处查看OMNI]()
OMNI
Business Intelligence (BI) Software
Stay up-to-date with all aspects of your KOL activity. OMNI makes it easy with complete coverage of both on and offline news delivered in real-time to your inbox and our user-friendly online platform.
地点
-
主要
获取路线
548 Mission St
Suite 44120
US，California，San Francisco，94105
LARVOL员工
动态
-
Oncologists on X are abuzz with the latest DESTINY-Gastric04 trial results! The phase 3 study revealed that ENHERTU? (trastuzumab deruxtecan) achieved a statistically significant and clinically meaningful improvement in overall survival (OS) compared to ramucirumab and paclitaxel in patients with second-line HER2-positive (IHC 3+ or IHC 2+/ISH+) unresectable or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma. #LARVOL #DESTINYGastric04 #Oncology #CancerResearch #CancerData #ClinicalTrials #OncologyDevelopments #ENHERTU #GastricCancer Connect with the oncologists who are buzzing about this on X: Prof. Dr. Arndt Vogel | Kohei Shitara, MD | Yakup ERGüN | Mohamad Bassam Sonbol | Erman Akkus, MD | Amol Akhade
-
-
Plan your 2025 conference schedule with our list of the Top 25 Oncology Conferences worldwide. Stay informed and connected. Follow us for more updates! #LARVOL #Oncology #CancerResearch #CancerData #CancerCare #OncologyUpdates #OncologyConferences #OncologyInsights #GI25 #GU25 #ASCO25 #EHA25 #AACR25 #ESMO25 #SITC25 #ASH25 #SABCS25 #2025Events #MedicalConferences
-
-
Watch the latest episode of LARVOL CLIN: Building in Public where Bruno Larvol and Judith Pérez showcase a new feature in CLIN i.e. Network Meta-Analysis. Watch now: https://lnkd.in/gRnQhDZp #LARVOL #Oncology #NetworkMetaAnalysis #ClinicalTrials #CancerResearch #LARVOLCLIN
-
-
Meet the top most active women oncologists on X: American Society of Clinical Oncology (ASCO)-GU 2025. Their active engagement and impactful contributions shaped the conversation. #LARVOL #WomenInOncology #CancerResearch #Oncology #GU25 #GUCancer #OncologyInsights #OncologyUpdates #CancerCare #CancerData Connect with these top women oncologists:?Dra. María Natalia Gandur Quiroga | Bárbara Mel?o | Jordan Ciuro | Karine Tawagi | Tian Zhang | Regina Barragán Carrillo | Rana McKay | Renee Maria Saliby | Dimitra Rafailia Bakaloudi MD, MS, MPA | Shilpa Gupta, MD | Amol Akhade
-
-
Matt Lewis & Mark Gramling discuss AI’s role in medical affairs and scientific publications. From sentiment analysis to research credibility, they break down how AI is shaping the industry both for better and worse. With real-world insights and a no-nonsense approach, this episode explores the opportunities that come with integrating AI in healthcare. #AI #LARVOL
#AI | LARVOL Onco Data Podcast with Matt Lewis
www.dhirubhai.net
-
This Friday, join Mark Gramling and AI expert Matt Lewis in the latest episode of LARVOL - Onco Data Podcast as they discuss AI advances in Healthcare Analytics and Communications. ? Don't miss this episode on Friday, 25th February at 2 PM PT. ? #LARVOL #OncoDataPodcast #Oncology #CancerResearch #AI #MedicalPodcast #CancerData
-
-
How is AI revolutionizing oncology data? Find out on Bloomberg! LARVOL is featured in a special "New Frontiers" episode, airing March 1st, 2025 at 5 PM EST. This episode explores the evolution of AI-Powered Oncology Data Intelligence with LARVOL. ? #LARVOL #Tech #Healthcare #BloombergTV #Oncology #CancerResearch #Cancer #CancerData #OncologyData
-
Oncologists on X are buzzing about the SERENA-6 trial. Camizestrant demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival in 1st-line advanced HR-positive breast cancer with an emergent ESR1 tumour mutation in SERENA-6 Phase III trial. #LARVOL #SERENA6 #Oncology #CancerResearch #CancerData #ClinicalTrials #OncologyDevelopments #Camizestrant #BreastCancer Connect with the oncologists who are buzzing about the SERENA-6 trial on X: Sara Tolaney | Paolo Tarantino | Komal Jhaveri | Erika Hamilton, MD | Giampaolo Bianchini | Amol Akhade
-